Foreign Filer Report • Aug 12, 2025
Foreign Filer Report
Open in ViewerOpens in native device viewer
For the month of August 2025
TAT TECHNOLOGIES LTD. (Name of Registrant)
Hamelacha 5, Netanya 4250540, Israel (Address of Principal Executive Office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [X] Form 40-F [ ]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): [ ]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): [ ]
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes [ ] No [X]
If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- ____________
TAT Technologies Ltd. (the "Company") hereby furnishes the following documents:
| Item/Exhibit No. | Description |
|---|---|
| 99.1 | Press Release dated August 11, 2025 re: TAT Technologies Ltd. |
| Reports Second Quarter 2025 Results. |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
TAT TECHNOLOGIES LTD. (Registrant)
By: /s/ Ehud Ben-Yair Ehud Ben-Yair Chief Financial Officer
Date: August 11, 2025
Netanya, Israel, August 11, 2025 - TAT Technologies Ltd. (NASDAQ and TASE: "TAT News") ("TAT" or the "Company") a leading provider of products and services to the commercial and military aerospace and ground defense industries, reported today its unaudited results for the three-month and six-month period ended June 30, 2025.
Financial highlights for the second quarter of 2025:
Mr. Igal Zamir, TAT's CEO and President, commented: "TAT Technologies delivered another quarter of organic growth and improved profitability, with second quarter revenue growing 18% year over year, adjusted EBITDA increasing 39%, and \$7 million in cash generated from operations. We continue to outpace the industry, despite certain slowdowns in MRO activity, by leveraging the diversification of our business across trading and MRO\OEM segments. Over the last month, MRO intake began to re-accelerate, providing greater visibility and reinforcing our confidence in continued year-over-year growth."
"In addition to the double-digit revenue growth, the value of our LTA and backlog grew by approximately \$85 million to \$524 million, which will flow into revenue over the coming years," added Mr. Zamir. "The broad-based growth was driven by winning several new contracts, including some for the 777APU, and also by increasing the volume of activity from existing contracts for both OEM and MRO."
Mr. Zamir continued, "This quarter, we successfully completed a capital raise of \$45 million, further strengthening our balance sheet. From this position of increased strength, we are continuing to evolve in alignment with the significant opportunities in front of us. Our diversified offering has positioned us to perform well relative to the broader market, and we are now beginning to explore accretive strategic opportunities to further enhance our growth prospects. As we scale, we are also taking steps to strengthen our Board of Directors with capabilities to support the next phase of the Company's development. We remain focused on scaling the business and creating tangible, long-term value for our shareholders."
With the growing LTA value and backlog, strong order intake, and the ramp up in MRO activity, we are confident in our ability to sustain growth and expand profit margins through 2026," concluded Mr. Zamir.
To supplement the consolidated financial statements presented in accordance with GAAP, the Company also presents Adjusted EBITDA. The adjustments to the Company's GAAP results are made with the intent of providing both management and investors with a more complete understanding of the Company's underlying operational results, trends and performance. Adjusted EBITDA is calculated as net income excluding the impact of: the Company's share in results of affiliated companies, share-based compensation, taxes on income, financial (expenses) income, net, and depreciation and amortization. Adjusted EBITDA, however, should not be considered as an alternative to net income and operating income for the period and may not be indicative of the historic operating results of the Company; nor is it meant to be predictive of potential future results. Adjusted EBITDA is not a measure of financial performance under generally accepted accounting principles and may not be comparable to other similarly titled measures for other companies. See reconciliation of Adjusted EBITDA below.
We are a leading provider of solutions and services to the aerospace and defense industries. We operate four operational units: (i) original equipment manufacturing ("OEM") of heat transfer solutions and aviation accessories through our Kiryat Gat facility (TAT Israel); (ii) maintenance repair and overhaul ("MRO") services for heat transfer components and OEM of heat transfer solutions through our subsidiary Limco Airepair Inc. ("Limco"); (iii) MRO services for aviation components through our subsidiary, Piedmont Aviation Component Services LLC ("Piedmont") (mainly Auxiliary Power Units ("APUs") and landing gear); and (iv) overhaul and coating of jet engine components through our subsidiary, Turbochrome Ltd. ("Turbochrome").
TAT's activities in the area of OEM of heat transfer solutions and aviation accessories through TAT Israel primarily include the design, development and manufacture of (i) a broad range of heat transfer solutions, such as pre-coolers heat exchangers and oil/fuel hydraulic heat exchangers, used in mechanical and electronic systems on board commercial, military and business aircraft; (ii) environmental control and power electronics cooling systems installed on board aircraft and ground applications; and (iii) a variety of mechanical aircraft accessories and systems such as pumps, valves, and turbine power units.
TAT's activities in the area of MRO and OEM of heat transfer solutions include the MRO of heat transfer components and to a lesser extent, the manufacturing of certain heat transfer solutions. TAT's Limco subsidiary operates a Federal Aviation Administration ("FAA") certified repair station, which provides heat transfer MRO services for airlines, air cargo carriers, maintenance service centers and the military.
TAT's activities in the area of MRO services for aviation components include the MRO of APUs and landing gear. TAT's Piedmont subsidiary operates an FAA-certified repair station, which provides aircraft component MRO services for airlines, air cargo carriers, maintenance service centers and the military.
TAT's activities in the area of jet engine overhaul through its Turbochrome facility includes the overhaul and coating of jet engine components, including turbine vanes and blades, fan blades, variable inlet guide vanes and afterburner flaps.
Contact: Mr. Eran Yunger Director of IR [email protected]
This press release and/or this report contains "forward-looking statements" within the meaning of the United States federal securities laws. These forward-looking statements include, without limitation, statements regarding possible or assumed future operation results. These statements are hereby identified as "forward-looking statements" for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve risks and uncertainties that could cause our results to differ materially from management's current expectations. Actual results and performance can also be influenced by other risks that we face in running our operations including, but are not limited to, general business conditions in the airline industry, changes in demand for our services and products, the timing and amount or cancellation of orders, LTAs and backlog, the price and continuity of supply of component parts used in our operations, and other risks detailed from time to time in the Company's filings with the Securities Exchange Commission, including, its annual report on form 20-F and its periodic reports on form 6-K. These documents contain and identify other important factors that could cause actual results to differ materially from those contained in our projections or forward-looking statements.
Shareholders and other readers are cautioned not to place undue reliance on these forwardlooking statements, which speak only as of the date on which they are made. We undertake no obligation to update publicly or revise any forward-looking statement.
| June 30, 2025 |
December 31, 2024 |
|
|---|---|---|
| ASSETS | ||
| CURRENT ASSETS: | ||
| Cash and cash equivalents | \$ 43,126 |
\$ 7,129 |
| Short-term bank deposits | 57 | - |
| Accounts receivable, net of allowance for credit losses of \$425 |
||
| and \$400 as of June 30, 2025, and December 31, 2024, respectively |
32,266 | 29,697 |
| Inventory | 76,414 | 68,540 |
| Prepaid expenses and other current assets | 6,610 | 7,848 |
| Total current assets | 158,473 | 113,214 |
| NON-CURRENT ASSETS: | ||
| Property, plant and equipment, net | 44,646 | 41,576 |
| Operating lease right of use assets | 3,475 | 2,282 |
| Intangible assets, net | 1,558 | 1,553 |
| Investment in affiliates | 4,188 | 2,901 |
| Funds in respect of employee rights upon retirement | 709 | 654 |
| Deferred income taxes | 295 | 877 |
| Restricted deposit | 291 | 305 |
| Total non-current assets | 55,162 | 50,148 |
| Total assets | \$ 213,635 | \$ 163,362 |
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||
| CURRENT LIABILITIES: | ||
| Current maturities of long-term loans | \$ 2,088 |
\$ 2,083 |
| Short-term loans | - | 4,350 |
| Accounts payable | 15,564 | 12,158 |
| Accrued expenses and other |
15,273 | 18,594 |
| Current maturities of operating lease liabilities | 993 | 939 |
| Total current liabilities | 33,918 | 38,124 |
| NON-CURRENT LIABILITIES: | ||
| Long-term loans | 10,310 | 10,938 |
| Liability in respect of employee rights upon retirement | 1,098 | 986 |
| Operating lease liabilities | 2,528 | 1,345 |
| Total non-current liabilities | 13,936 | 13,269 |
| COMMITMENTS AND CONTINGENCIES (NOTE 4) | - | - |
| Total liabilities | 47,854 | 51,393 |
| SHAREHOLDERS' EQUITY: | ||
|---|---|---|
| Ordinary shares of NIS 0 par value at June 30, 2025 and at | ||
| December 31, 2024 respectively | ||
| Authorized: 15,000,000 shares at June 30, 2025 and 13,000,000 at |
||
| December 31, 2024; Issued: 13,161,762 and 11,214,831 shares | ||
| at June 30, 2025 and at December 31, 2024, respectively; |
||
| Outstanding: 12,887,289 and 10,940,358 shares at June 30, 2025 |
||
| and at December 31, 2024, respectively | - | - |
| Additional paid-in capital | 135,578 | 89,697 |
| Treasury stock at cost | (2,088) | (2,088) |
| Accumulated other comprehensive income (loss) | 600 | (76) |
| Retained earnings | 31,691 | 24,436 |
| Total shareholders' equity | 165,781 | 111,969 |
| Total liabilities and shareholders' equity | \$ 213,635 |
\$ 163,362 |
| Three months ended June 30, |
Six months ended June 30, |
|||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Revenues: | ||||
| Products | \$ 12,463 | \$ 11,732 |
\$ 25,187 |
\$ 23,667 |
| Services | 30,641 | 24,793 | 60,059 | 46,946 |
| 43,104 | 36,525 | 85,246 | 70,613 | |
| Cost of goods: | ||||
| Products | 9,112 | 7,673 | 17,443 | 16,659 |
| Services | 23,167 | 20,868 | 47,024 | 38,904 |
| 32,279 | 28,541 | 64,467 | 55,563 | |
| Gross profit | 10,825 | 7,984 | 20,779 | 15,050 |
| Operating expenses: | ||||
| Research and development, net | 240 | 343 | 564 | 620 |
| Selling and marketing | 2,185 | 1,993 | 4,113 | 3,653 |
| General and administrative | 3,965 | 2,916 | 7,497 | 6,225 |
| Other income | - | (2) | - | (390) |
| 6,390 | 5,250 | 12,174 | 10,108 | |
| Operating income | 4,435 | 2,734 | 8,605 | 4,942 |
| Interest expenses | (324) | (413) | (659) | (763) |
| Other financial income (expenses), net | (776) | 106 | (499) | 7 |
| Income before taxes on income (taxes benefit) |
3,335 | 2,427 | 7,447 | 4,186 |
| Provision for taxes on income (taxes benefit) |
211 | 44 | 803 | (109) |
| Profit before share of equity investment | 3,124 | 2,383 | 6,644 | 4,295 |
| Share in profits of equity investment of |
||||
| affiliated companies | 318 | 234 | 611 | 432 |
| Net income | \$ 3,442 |
\$ 2,617 |
\$ 7,255 | \$ 4,727 |
| Earnings per share | ||||
|---|---|---|---|---|
| Basic | \$ 0.30 | \$ 0.26 |
\$ 0.65 | \$ 0.46 |
| Diluted | \$ 0.30 | \$ 0.25 | \$ 0.64 | \$ 0.44 |
| Weighted average number of shares outstanding |
||||
| Basic | 11,447,986 | 10,394,654 | 11,196,992 | 10,386,859 |
| Diluted | 11,666,309 | 10,561,420 | 11,409,488 | 10,722,153 |
| Three Months Ended June 30, |
Six Months Ended June 30, |
|||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Net income | \$ 3,442 | \$ 2,617 |
\$ 7,255 | \$ 4,727 |
| Other comprehensive income (loss), net | ||||
| Net unrealized losses from derivatives Change in foreign currency translation |
- | - | - | (27) |
| adjustments | 148 | 164 | 676 | 164 |
| Total comprehensive income | \$ 3,590 | \$ 2,781 | \$ 7,931 | \$ 4,864 |
| Share capital | Accumulated | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of shares issued |
Amount | Additional paid-in capital |
other comprehensive income (loss) |
Treasury shares |
Retained earnings |
Total equity | |||||||
| BALANCE AT DECEMBER 31, 2023 CHANGES DURING THE 6 MONTHS ENDED JUNE 30, 2024: |
10,377,085 | \$ | 3,140 | \$ | 76,335 | \$ | 27 | \$ (2,088) | \$ 13,269 |
\$ | 90,683 | ||
| Comprehensive income | - | - | - | 137 | - | 4,727 | 4,864 | ||||||
| Exercise of option | 49,109 | 12 | )12( | - | - | - | - | ||||||
| Share based compensation | - | - | 189 | - | - | - | 189 | ||||||
| BALANCE AT JUNE 30, 2024 |
10,426,194 | 3,152 | 76,512 | 164 | (2,088) | 17,996 | 95,736 | ||||||
| BALANCE AT DECEMBER 31, 2024 CHANGES DURING THE 6 MONTHS ENDED JUNE 30, 2025: |
11,214,831 | - | 89,697 | (76) | (2,088) | 24,436 | 111,969 | ||||||
| Comprehensive income | - | - | - | 676 | - | 7,255 | 7,931 | ||||||
| Exercise of option | 79,633 | - | - | - | - | - | - | ||||||
| Issuance of common shares on public offering, net of issuance costs of \$2,769 |
1,625,000 | - | 39,415 | - | - | - | 39,415 | ||||||
| Exercise of the underwriters' option on public offering, net of issuance costs of \$413 |
242,298 | - | 5,953 | - | - | - | 5,953 | ||||||
| Share based compensation | - | - | 513 | - | - | - | 513 | ||||||
| BALANCE AT JUNE 30, 2025 |
13,161,762 | \$ | - | \$ 135,578 | \$ | 600 | \$ (2,088) | \$ 31,691 | \$ 165,781 |
| Share capital | Accumulated | |||||||
|---|---|---|---|---|---|---|---|---|
| Number of shares issued |
Amount | Additional paid-in capital |
other comprehensive income |
Treasury shares |
Retained earnings |
Total equity | ||
| BALANCE AT MARCH 31, 2024 CHANGES DURING THE 3 MONTHS ENDED JUNE 30, 2024: |
10,382,637 | \$ 3,141 |
\$ 76,376 |
\$ - |
\$ (2,088) | \$ 15,379 |
\$ 92,808 | |
| Comprehensive income | - | - | - | 164 | - | 2,617 | 2,781 | |
| Exercise of option | 43,557 | 11 | )12( | - | - | - | (1) | |
| Share based compensation | - | - | 148 | - | - | - | 148 | |
| BALANCE AT JUNE 30, 2024 |
10,426,194 | 3,152 | 76,512 | 164 | (2,088) | 17,996 | 95,736 | |
| BALANCE AT MARCH 31, 2025 CHANGES DURING THE 3 MONTHS ENDED JUNE 30, 2025: |
11,214,831 | - | 89,919 | 452 | (2,088) | 28,249 | 116,532 | |
| Comprehensive income | - | - | - | 148 | - | 3,442 | 3,590 | |
| Exercise of stock option | 79,633 | - | - | - | - | - | - | |
| Issuance of common shares on public offering, net of issuance costs of \$2,769 |
1,625,000 | - | 39,415 | - | - | - | 39,415 | |
| Exercise of the underwriters' option on public offering, net of issuance costs of \$413 |
242,298 | - | 5,953 | - | - | - | 5,953 | |
| Share based compensation | - | - | 291 | - | - | - | 291 | |
| BALANCE AT JUNE 30, 2025 |
13,161,762 | \$ - |
\$ 135,578 | \$ 600 | \$ (2,088) |
\$ 31,691 | \$ 165,781 |
| Three Months Ended June 30, |
Six Months Ended June 30, |
||||
|---|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | ||
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||
| Net income | \$ 3,442 | \$ 2,617 | \$ 7,255 | \$ 4,727 | |
| Adjustments to reconcile net income to net cash used in operating activities: | |||||
| Depreciation and amortization | 1,208 | 1,431 | 2,513 | 2,805 | |
| Non-cash financial (income) expenses | 600 | (276) | 508 | (486) | |
| Change in allowance for credit losses | 75 | 40 | 25 | 40 | |
| Share in profits of equity investment of affiliated companies | (318) | (234) | (611) | (432) | |
| Share based compensation | 291 | 148 | 513 | 189 | |
| Gain on disposal of property, plant and equipment | - | (1) | - | (355) | |
| Deferred income taxes, net | 63 | 306 | 582 | (103) | |
| Changes in operating assets and liabilities: | |||||
| Decrease (increase) in trade accounts receivable | 882 | (5,430) | (2,594) | (6,250) | |
| Decrease (increase) in prepaid expenses and other current assets | 1,697 | (129) | 1,183 | (283) | |
| Increase in inventory | (3,434) | (2,906) | (7,295) | (5,543) | |
| Increase (decrease) in trade accounts payable | 2,972 | (209) | 3,406 | (909) | |
| Decrease (increase) in accrued expenses and other | (529) | 543 | (3,571) | (1,047) | |
| Net cash provided by (used in) operating activities | 6,949 | (4,100) | 1,914 | (7,647) | |
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||
| Proceeds from sale of property and equipment | - | - | - | 1,306 | |
| Purchase of property and equipment | (3,305) | (978) | (6,167) | (1,967) | |
| Net cash used in investing activities | (3,305) | (978) | (6,167) | (661) | |
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||
| Repayments of long-term loans | (516) | (510) | (1,087) | (950) | |
| Proceeds from issuance of ordinary shares and exercise of the underwriters' | |||||
| option | 48,550 | (1) | 48,550 | - | |
| Issuance costs of ordinary shares and exercise of the underwriters' option | (2,820) | - | (2,820) | - | |
| Net change in short term loans from banks | (10,719) | 4,668 | (4,350) | 668 | |
| Net cash provided by (used in) financing activities | 34,495 | 4,157 | 40,293 | (282) | |
| Net increase (decrease) in cash and cash equivalents and restricted cash | 38,139 | (921) | 36,040 | (8,590) | |
| Cash and cash equivalents and restricted cash at beginning of period | 5,335 | 9,273 | 7,434 | 16,942 | |
| Cash and cash equivalents and restricted cash at the end of period | \$ 43,474 | \$ 8,352 | \$ 43,474 | \$ 8,352 | |
| Supplementary information on investing and financing activities not involving cash flows: |
|||||
| Additions of operating lease right-of-use assets and operating lease liabilities | \$ 1,688 | \$ 245 | \$ 1,835 |
\$ 590 |
|
| Reclassification between inventory and property, plant and equipment | - | - | 579 | 60 | |
| Unpaid issuance costs of ordinary shares and exercise of the underwriters' | |||||
| option | 362 | - | 362 | - | |
| Supplemental disclosure of cash flow information: | |||||
| Interest paid | 249 | 410 | |||
| 516 | 852 |
RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA (NON-GAAP) (UNAUDITED)
(U.S dollars in thousands)
| Three months ended June 30, |
Six months ended June 30, |
||||
|---|---|---|---|---|---|
| 2025 | 2024 | 2024 | |||
| Net income | \$ 3,442 | \$ 2,617 | \$ 7,255 | \$ 4,727 | |
| Adjustments: | |||||
| Share in results and sale of equity | |||||
| investment of affiliated companies | (318) | (234) | (611) | (432) | |
| Taxes on income (tax benefit) | 211 | 44 | 803 | (109) | |
| Financial expenses, net | 1,100 | 306 | 1,158 | 756 | |
| Depreciation and amortization | 1,328 | 1,468 | 2,691 | 2,898 | |
| Share based compensation | 291 | 148 | 513 | 189 | |
| Adjusted EBITDA | \$ 6,054 | \$ 4,349 | \$ 11,809 | \$ 8,029 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.